Change in Aiforia Technologies Plc’s Management Team

Aiforia Technologies Plc, Company Release, December 22, 2025 at 4.00 p.m. EET

Aiforia Technologies Plc has appointed Antti Ojala (M.Sc. Econ., M.Sc. Eng.) as the company's Chief Financial Officer and a member of the Management Team. He will start in his position at the latest on March 2, 2026.

Antti Ojala has over 15 years of solid, versatile experience in financial management, particularly in health technology and diagnostics companies. He joins Aiforia from Aurevia Oy, where he has served as CFO and been responsible for financing operations. Earlier in his career, he has, among other things, led financial operations at Mobidiag Oy.

"I am very pleased to have Antti Ojala join the Management Team to support the company's next phase," says Aiforia's CEO Jukka Tapaninen. "His experience and track record in leading strategic projects and investor relations, as well as the use of various financing instruments, are a significant addition to our team as we accelerate our growth and strengthen our position as a pioneer in AI-based diagnostics."

Aiforia's current CFO Veli-Matti Parkkonen, is leaving the company after serving as the company's CFO and a member of the Management Team for several years during the company's significant growth phase. Parkkonen will continue in the company until March 31, 2026.

"I want to express my deepest gratitude to Veli-Matti for his service at Aiforia over the years. With his commitment and big heart, he has made a significant contribution to the company's growth path and operations as a listed company,” says Jukka Tapaninen, CEO of Aiforia Technologies Plc.

Further inquiries
Jukka Tapaninen, CEO, Aiforia Technologies Plc
tel. +33 61 041 6686
https://investors.aiforia.com/

Certified Adviser 
UB Corporate Finance Ltd
ubcf@unitedbankers.fi

About Aiforia 

Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers advanced software solutions that elevate diagnostic capabilities in image analysis, empowering remarkable medical discoveries both today and in the future. With thousands of AI models developed for research use and several diagnostic solutions deployed, Aiforia is making a significant impact on pathology and healthcare. In Europe, Aiforia is the leading provider of CE-IVD marked AI-powered solutions for digital pathology.

Founded in 2013, Aiforia is a publicly traded company with a global presence and thousands of users worldwide. Headquartered in Helsinki, Finland, the company also operates subsidiaries in the United States and France, and maintains a network of local representatives across Europe and North America. Aiforia’s diverse team includes experienced AI and software developers, pathologists, medical scientists, and a dedicated commercial team. Together, they are transforming pathology through AI, enabling better care for every patient. 

Find out more at www.aiforia.com